← Back to Patent Explorer
US5677140A Expired / Lapsed US ⏱️ 0.0 years remaining

Process and test kit for determining the bacterial count level in whey and whey products

Assignee: Biolac GmbH
•
Filing: 1996-01-30
•
Granted: 1997-10-14
•
Expires: 2016-01-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for rapidly determining the bacterial count level in whey or whey constituents by adding a bacteria lysing reagent and then a luciferin-luciferase reagent to a sample to be analyzed at a pH from 7.0 to 7.9 and then measuring the bioluminescence light emitted from the luciferase-luciferin reaction, and an analysis kit for carrying out the process.

Inventors

  • 👤 Hans-Joerg Denzler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 02:00
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/02; C12Q1/04; C12Q1/06; C12Q1/66; G; G01; G01N; G01N33/00; G01N33/02; G01N33/04; Y; Y10; Y10S; Y10S435/00; Y10S435/968

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 310 words
A process for rapid determination of the bacterial count level in a sample of whey or whey constituents to be analyzed, said process comprising: a) preparing the sample for bioluminescence measurement by aa) wherein the sample is whey, aa1) diluting the whey sample with a reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol; aa2) separating the diluted whey sample by centrifugation into a liquid phase and an solid residue; aa3) converting the solid residue into a suspension by adding a reagent solution containing a bacteriolytic reagent; aa4) forming a reaction mixture by mixing the suspension with a reagent solution which hydrolyzes adenosine triphosphate; aa5) allowing the reaction mixture from step aa4) to react for a time sufficient to hydrolyze ATP present therein and to inactivate excess adenosine triphosphate hydrolyzing reagent; or ab1) introducing the whey constituent sample into an aqueous, isotonic salt solution; ab2) filtering the solution containing the sample through a sterile filter; ab3) transferring the filter with retained bacteria thereon into a nutrient solution suitable for culturing bacteria; incubating this solution for 1 to 9 hours at 28° C. to 38° C., and subsequently using the nutrient solution from above the filter as a reaction mixture for further measurement; b) releasing bacterial adenosine triphosphate in the reaction mixture obtained from process steps aa1) to aa5) or ab1) to ab3) by treatment with a reagent which releases bacterial adenosine triphosphate; c) adding to the reaction mixture a luciferin-luciferase reagent solution buffered to a pH value of from 7.0 to 7.9 in order to effect a bioluminescence reaction with released adenosine triphosphate; d) photometrically quantitatively measuring light emitted during the bioluminescence reaction, and e) determining the bacterial count level in the sample to be analyzed by comparing the measured light quantity with a standard curve produced under the same conditions with a sample of similar origin having a known bacterial count level.
Claim 2
Dependent Claim 310 words
A process for rapid determination of the bacterial count level in a sample of whey or whey constituents to be analyzed, said process comprising: a) preparing the sample for bioluminescence measurement by aa) wherein the sample is whey, aa1) diluting the whey sample with a reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol; aa2) separating the diluted whey sample by centrifugation into a liquid phase and an solid residue; aa3) converting the solid residue into a suspension by adding a reagent solution containing a bacteriolytic reagent; aa4) forming a reaction mixture by mixing the suspension with a reagent solution which hydrolyzes adenosine triphosphate; aa5) allowing the reaction mixture from step aa4) to react for a time sufficient to hydrolyze ATP present therein and to inactivate excess adenosine triphosphate hydrolyzing reagent; or ab1) introducing the whey constituent sample into an aqueous, isotonic salt solution; ab2) filtering the solution containing the sample through a sterile filter; ab3) transferring the filter with retained bacteria thereon into a nutrient solution suitable for culturing bacteria; incubating this solution for 1 to 9 hours at 28° C. to 38° C., and subsequently using the nutrient solution from above the filter as a reaction mixture for further measurement; b) releasing bacterial adenosine triphosphate in the reaction mixture obtained from process steps aa1) to aa5) or ab1) to ab3) by treatment with a reagent which releases bacterial adenosine triphosphate; c) adding to the reaction mixture a luciferin-luciferase reagent solution buffered to a pH value of from 7.0 to 7.9 in order to effect a bioluminescence reaction with released adenosine triphosphate; d) photometrically quantitatively measuring light emitted during the bioluminescence reaction, and e) determining the bacterial count level in the sample to be analyzed by comparing the measured light quantity with a standard curve produced under the same conditions with a sample of similar origin having a known bacterial count level.
Claim 3
Dependent Claim 43 words
The process according to claim 1, wherein the sample is whey, and in step aa5) the reaction mixture from step aa4) is allowed to react for about 20 minutes in order to hydrolyze ATP present therein and to inactivate excess ATP hydrolyzing reagent.
Claim 4
Dependent Claim 24 words
The process according to claim 1, wherein the sample is a whey constituent, and the aqueous, isotonic solution in step ab1) is Ringer's solution.
Claim 5
Dependent Claim 16 words
The process according to claim 1, wherein the sample to be analyzed is a whey constituent.
Claim 6
Dependent Claim 15 words
The process according to claim 4, wherein the sample to be analyzed is lactose powder.
Claim 7
Dependent Claim 16 words
The process according to claim 4, wherein the sample to be analyzed is whey protein powder.
Claim 8
Dependent Claim 276 words
An analysis kit for determining the bacterial count level in whey in which a whey sample is diluted with a reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol, the diluted sample is separated by centrifugation into a liquid phase and a solid residue, the solid residue is converted to a suspension by introducing it into a reagent solution containing a bacteriolytic reagent, the suspension is mixed with an adenosine triphosphate hydrolyzing reagent solution to form a reaction mixture, the reaction mixture is allowed to react for a time sufficient to hydrolyze ATP present therein and to inactivate excess adenosine triphosphate hydrolyzing reagent, bacterial adenosine triphosphate in the reaction mixture is released by treatment with a reagent which releases bacterial adenosine triphosphate, a luciferin-luciferase reagent solution buffered to a pH of 7.0 to 7.9 is added to the reaction mixture in order to effect a bioluminescence reaction with released adenosine triphosphate, light emitted during the bioluminescence reaction is photometrically measured, and the bacterial count level in the whey sample to be analyzed is determined by comparison with a standard curve produced under the same conditions from a whey sample of similar origin having a known bacterial count; wherein said analysis kit comprises: a) a reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol; b) a bacteriolytically active reagent solution; c) reagents for preparing an adenosine triphosphate hydrolyzing reagent solution, namely: c1) somase in freeze-dried form; c2) ethylenediaminetetraacetic acid disodium salt in solid form, and c3) a liquid solution of a reagent for releasing nucleotides from somatic cells; d) a bacterial adenosine triphosphate releasing reagent solution; e) a luciferin-luciferase reagent, and f) a buffer solution buffering at a pH of 7.0 to 7.9.
Claim 9
Dependent Claim 276 words
An analysis kit for determining the bacterial count level in whey in which a whey sample is diluted with a reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol, the diluted sample is separated by centrifugation into a liquid phase and a solid residue, the solid residue is converted to a suspension by introducing it into a reagent solution containing a bacteriolytic reagent, the suspension is mixed with an adenosine triphosphate hydrolyzing reagent solution to form a reaction mixture, the reaction mixture is allowed to react for a time sufficient to hydrolyze ATP present therein and to inactivate excess adenosine triphosphate hydrolyzing reagent, bacterial adenosine triphosphate in the reaction mixture is released by treatment with a reagent which releases bacterial adenosine triphosphate, a luciferin-luciferase reagent solution buffered to a pH of 7.0 to 7.9 is added to the reaction mixture in order to effect a bioluminescence reaction with released adenosine triphosphate, light emitted during the bioluminescence reaction is photometrically measured, and the bacterial count level in the whey sample to be analyzed is determined by comparison with a standard curve produced under the same conditions from a whey sample of similar origin having a known bacterial count; wherein said analysis kit comprises: a) a reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol; b) a bacteriolytically active reagent solution; c) reagents for preparing an adenosine triphosphate hydrolyzing reagent solution, namely: c1) somase in freeze-dried form; c2) ethylenediaminetetraacetic acid disodium salt in solid form, and c3) a liquid solution of a reagent for releasing nucleotides from somatic cells; d) a bacterial adenosine triphosphate releasing reagent solution; e) a luciferin-luciferase reagent, and f) a buffer solution buffering at a pH of 7.0 to 7.9.
Claim 10
Dependent Claim 24 words
The analysis kit according to claim 7, wherein the reagent solution containing ethoxylate of 4-(1,1,3,3-tetramethylbutyl)phenol further comprises at least one chemical emulsifier or detergent.
Claim 11
Dependent Claim 19 words
The analysis kit according to claim 7, wherein the bacteriolytically active reagent solution comprises lysozyme and a chemical stabilizer.
Claim 12
Dependent Claim 37 words
An analysis kit according to claim 7, wherein the bacterial adenosine triphosphate hydrolyzing reagent solution comprises somase and a 2 to 7 wt-% solution of trichloroacetic acid containing 3 to 4 mg/ml disodium salt of ethylenediaminetetraacetic acid.
Claim 13
Dependent Claim 41 words
The analysis kit according to claim 7, wherein the buffer solution buffering at a pH of 7.0 to 7.9 is an aqueous solution comprising 25 mmole/liter N-2-hydroxyethylpiperazin-N'-2-ethanesulfonic acid buffer, 7.5 mmole/liter magnesium sulfate and 1 mmole/liter disodium salt of ethylenediaminetetraacetic acid.

References Cited (Backward Citations)

US3616253A Cited
GB2001434A Cited
EP0299601A1 Cited
EP0309429A2 Cited
EP0441469A1 Cited
WO1992000317A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-10-13 2001-04-14 2001-10-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-10-13 2005-04-14 2005-10-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-10-13 2009-04-14 2009-10-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag